We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Standard BioTools
LAB
$326M
| $397K | 0.01% |
32,199
-249,996
| -89% | -$3.18M |
|
|
HONE
777
DELISTED
HarborOne Bancorp
HONE
| $392K | 0.01% |
37,605
-7,719
| -17% | -$78.1K |
|
778
Ecovyst
ECVT
$1.36B
| $391K | 0.01% |
24,660
-100
| -0.4% | -$1.57K |
|
779
Kinsale Capital Group
KNSL
$7.95B
| $388K | 0.01% |
4,240
-10,898
| -72% | -$870K |
|
780
LivaNova
LIVN
$4.3B
| $381K | 0.01% |
+5,300
| New | +$388K |
|
781
T-Mobile US
TMUS
$193B
| $381K | 0.01% |
+5,140
| New | +$382K |
|
|
XLNX
782
DELISTED
Xilinx Inc
XLNX
| $380K | 0.01% |
3,220
-3,600
| -53% | -$420K |
|
|
CALA
783
DELISTED
Calithera Biosciences, Inc
CALA
| $379K | 0.01% |
4,861
+1,583
| +48% | +$180K |
|
|
ADVM
784
DELISTED
Adverum Biotechnologies
ADVM
| $378K | 0.01% |
3,180
-1,180
| -27% | -$97.6K |
|
|
DSPG
785
DELISTED
DSP Group Inc
DSPG
| $376K | 0.01% |
26,209
-44,748
| -63% | -$645K |
|
786
Altisource Portfolio Solutions
ASPS
$65.4M
| $370K | 0.01% |
+2,355
| New | +$418K |
|
|
SEAC
787
DELISTED
Seachange International Inc
SEAC
| $364K | 0.01% |
12,722
| – | – |
|
|
INFI
788
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $363K | 0.01% |
201,438
+9,511
| +5% | +$15.3K |
|
|
EEX
789
DELISTED
Emerald Holding
EEX
| $362K | 0.01% |
32,493
| – | – |
|
790
Aquestive Therapeutics
AQST
$462M
| $361K | 0.01% |
+85,896
| New | +$440K |
|
791
Pixelworks
PXLW
$38.8M
| $356K | ﹤0.01% |
10,056
-4,607
| -31% | -$198K |
|
792
Paychex
PAYX
$40.4B
| $351K | ﹤0.01% |
4,260
+1,600
| +60% | +$135K |
|
|
FBMS
793
DELISTED
The First Bancshares, Inc.
FBMS
| $349K | ﹤0.01% |
11,508
-2,280
| -17% | -$69.7K |
|
|
HIBB
794
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $349K | ﹤0.01% |
19,160
-97,623
| -84% | -$2.05M |
|
|
RYZ
795
Ryerson Holding Corp
RYZ
$1.6B
| $345K | ﹤0.01% |
41,439
+1,800
| +5% | +$15.8K |
|
796
United Fire Group
UFCS
$1.32B
| $345K | ﹤0.01% |
7,120
-1,500
| -17% | -$68.5K |
|
797
Whirlpool
WHR
$2.42B
| $345K | ﹤0.01% |
2,420
-41,160
| -94% | -$5.52M |
|
|
HIVE
798
DELISTED
Aerohive Networks
HIVE
| $345K | ﹤0.01% |
77,784
-445,897
| -85% | -$1.61M |
|
799
Dana Inc
DAN
$2.91B
| $341K | ﹤0.01% |
17,100
-619,321
| -97% | -$11M |
|
800
Forestar Group
FOR
$1.44B
| $341K | ﹤0.01% |
+17,425
| New | +$321K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.